Skip to the page

Data / Form D filings / PANGIA BIOTECH, INC.

PANGIA BIOTECH, INC.: Form D filing

PANGIA BIOTECH, INC., a biotechnology company in Delray Beach, FL, filed a Form D with the SEC in 2026. The latest, on May 11, 2026, reports $1.6 million sold of a $1.6 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4733 WEST ATLANTIC AVENUE SUITE C-14, Delray Beach, FL, 33445
Phone
(855) 561-4733
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Florida
Year incorporated
2023
Revenue range
Not Applicable
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
2125789

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 11, 2026New notice$1,580,000$1,580,00018Apr 8, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Holly MagliochettiExecutive Officer, Director
Joseph FrattaroliExecutive Officer
Obdulio PilotoExecutive Officer
Caroline PopperExecutive Officer
Garth Lees-RolfeDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of May 11, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PANGIA BIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.